19 dec2020
illumina stock forecast
This puts Doug Parker in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. The life sciences company can be reached via phone at 858-202-4500 or via email at [email protected]. Illumina had a net margin of 19.70% and a return on equity of 15.93%. You may vote once every thirty days. Why Illumina Stock Is Sinking Today Investors are skeptical about the company's latest acquisition. View our full suite of financial calendars and market data tables, all for free. (NASDAQ: ILMN) Illumina's forecast annual revenue growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 22.71%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 70.52%. Illumina Inc quote is equal to 390.650 USD at 2021-01-20. The business's revenue for the quarter was down 12.5% compared to the same quarter last year. Identify stocks that meet your criteria using seven unique stock screeners. What is ILMN's revenue growth forecast for 2021-2022? (Add your “outperform” vote. Illumina has received a consensus rating of Hold. ILMN's Return on Equity is forecast to be low in 2 years (19.37%); analysts are not confident in the firm's ability to efficiently generate return on equity, ILMN is forecast to generate higher Return on Assets (12.29%) than the US Diagnostics & Research industry average (9.23%), ILMN's earnings are forecast to grow at an exceptional rate of 20.56% per year, ILMN's earnings are forecast to grow slower (20.56% per year) than the US Diagnostics & Research industry average (70.46%), ILMN's earnings are forecast to grow slower (20.56% per year) than the US market average (113.21%), ILMN's earnings are forecast to grow faster (20.56% per year) than the risk-free savings rate (1.1%). Illumina's earnings in 2020 is $638,000,000.On average, 4 Wall Street analysts forecast ILMN's earnings for 2021 to be $763,945,000, with the lowest ILMN earnings forecast at $750,440,000, and the highest ILMN earnings forecast at $779,640,000. See Illumina, Inc. (ILMN) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in certain markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. Illumina has a market capitalization of $59.31 billion and generates $3.54 billion in revenue each year. Based on our forecasts, a long-term increase is expected, the "ILMN" stock price prognosis for 2026-01-14 is 512.164 USD. Shares of Illumina stock have risen exponentially in the nearly two decades since it entered its initial public offering. 19 brokerages have issued 12 month target prices for Illumina's stock. On average, they expect Illumina's stock price to reach $333.30 in the next twelve months. Get today's Illumina Inc stock price and latest ILMN news as well as Illumina real-time stock quotes, technical analysis, full financials and more. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California. Is Illumina Stock a good buy in 2020, according to Wall Street analysts? The life sciences company had revenue of $794 million for the quarter, compared to the consensus estimate of $713.97 million. Illumina does not have a long track record of dividend growth. View analysts' price targets for Illumina or view Wall Street analyst' top-rated stocks. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Shares of ILMN can be purchased through any online brokerage account. According to 16 Wall Street analysts that have issued a 1 year ILMN price target, the average ILMN price target is $327.69, with the highest ILMN stock price forecast at $415.00 and the lowest ILMN stock price forecast at $250.00. Some companies that are related to Illumina include Thermo Fisher Scientific (TMO), Agilent Technologies (A), Mettler-Toledo International (MTD), Bio-Rad Laboratories (BIO), PerkinElmer (PKI), Waters (WAT), Charles River Laboratories International (CRL), Bio-Techne (TECH), Bruker (BRKR), Pacific Biosciences of California (PACB), Luminex (LMNX), Fluidigm (FLDM), Harvard Bioscience (HBIO), aTyr Pharma (LIFE) and BG Medicine (BGMD). 1,448 employees have rated Illumina CEO Doug Parker on Glassdoor.com. Keith Speights (TMFFishBiz) Sep 21, 2020 at 12:15PM Author Bio. ILMN stock was sold by a variety of institutional investors in the last quarter, including Frontier Capital Management Co. LLC, Waverton Investment Management Ltd, Gateway Investment Advisers LLC, Pacer Advisors Inc., Douglas Lane & Associates LLC, Windward Capital Management Co. CA, Altfest L J & Co. Inc., and Appleton Partners Inc. MA. On average, Wall Street analysts predict that Illumina's share price could fall to $327.69 by Jan 13, 2022. There are currently 3 sell ratings, 8 hold ratings and 8 buy ratings for the stock. Illumina Inc. stock outperforms market on strong trading day Jan. 21, 2021 at 5:31 p.m. Illumina has a P/B Ratio of 12.95. WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. and has now fallen 4 days in a row. He’s now moved $3.8 BILLION in a tiny niche of the tech sector billionaires are flocking to…. Illumina Inc ⦠View Illumina, Inc. ILMN investment & stock information. Illumina News: ILMN Stock 4% Lower on Weak 2020 Outlook The life sciences company reported $1.02 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.77 by $0.25. See what's happening in the market right now with MarketBeat's real-time news feed. Illumina does not currently pay a dividend. Earnings for Illumina are expected to grow by 19.13% in the coming year, from $4.39 to $5.23 per share. The Illumina stock price fell by -0.55% on the last day (Wednesday, 30th Dec 2020) from $366.11 to $364.09. Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. ... Top Blogger Bullish Predictions . Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. Illumina employs 7,700 workers across the globe. This price target is based on 19 analysts offering 12 month price targets for Illumina in the last 3 months. Illumina last announced its earnings data on October 29th, 2020. 7 Electric Vehicle (EV) Stocks That Have Real Juice, 7 Post-Inauguration Stocks to Buy For Under $20, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, view Wall Street analyst' top-rated stocks, Charles River Laboratories International (CRL), Receive Analysts' Upgrades and Downgrades Daily. Illumina's revenue in 2020 is $3,238,000,000.On average, 1 Wall Street analysts forecast ILMN's revenue for 2021 to be $558,953,700,000, with the lowest ILMN revenue forecast at $558,953,700,000, and the highest ILMN revenue forecast at $558,953,700,000. Illumina is scheduled to release its next quarterly earnings announcement on Wednesday, February 3rd 2021. What is ILMN's earnings growth forecast for 2021-2022? High institutional ownership can be a signal of strong market trust in this company. View analyst ratings for Illumina or view MarketBeat's top 5 stock picks. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 The company went public at $16 per share on July 28, 2000. 89.97% of the stock of Illumina is held by institutions. What is ILMN's forecast return on assets (ROA) for 2021-2022? View which stocks have been most impacted by COVID-19. Get short term trading ideas from the MarketBeat Idea Engine. Learn more. Top institutional shareholders include Douglas Lane & Associates LLC (0.23%), Sarasin & Partners LLP (0.13%), Ardevora Asset Management LLP (0.10%), DAVENPORT & Co LLC (0.10%), Waverton Investment Management Ltd (0.07%) and Frontier Capital Management Co. LLC (0.06%). Down 28.5% In 24 Hours, Where Does Ethereum (ETH) Go From Here? View insider buying and selling activity for Illumina or or view top insider-buying stocks. (Add your “underperform” vote.). Vote “Outperform” if you believe ILMN will outperform the S&P 500 over the long term. In the past three months, Illumina insiders have sold more of their company's stock than they have bought. Illumina's stock was trading at $246.01 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Illumina, Inc. ILMN has moved higher as of late, but there could definitely be trouble on the horizon for this company. Illumina trades on the NASDAQ under the ticker symbol "ILMN.". The average price target is $333.30, with a high forecast of $415.00 and a low forecast of $280.00. Illumina (ILMN) stock price prediction is 665.102327 USD. Here's Why You Should Hold on to Illumina (ILMN) Stock for Now 12/31/20-8:39AM EST Zacks Illumina (ILMN)-Harvard Pilgrim Partner to Expand WGS Access 12/09/20-7:18AM EST Zacks. Company insiders that own Illumina stock include Aimee L Hoyt, Charles Dadswell, Frances Arnold, Francis A Desouza, Jay T Flatley, Karen K Mcginnis, Mostafa Ronaghi, Oene Mark Van, Omead Ostadan, Phillip G Febbo, Robert P Ragusa, Robert S Epstein, Sam Samad and Susan H Tousi. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. View which stocks are hot on social media with MarketBeat's trending stocks report. And bought this instead! Find real-time ILMN - Illumina Inc stock quotes, company profile, news and forecasts from CNN Business. The company's average rating score is 2.26, and is based on 8 buy ratings, 8 hold ratings, and 3 sell ratings. Learn about financial terms, types of investments, trading strategies and more. In 2022, ILMN is forecast to generate $677,732,438,000 in revenue, with the lowest revenue forecast at $653,774,860,000 and the highest revenue forecast at $712,677,100,000. The life sciences company earns $1.00 billion in net income (profit) each year or $6.57 on an earnings per share basis. In 2022, ILMN is forecast to generate $910,164,000 in earnings, with the lowest earnings forecast at $640,940,000 and the highest earnings forecast at $1,258,520,000. The average Illumina stock price prediction forecasts a potential downside of 19.34% from the current ILMN share price of $406.25. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements. Stock Price Forecast The 16 analysts offering 12-month price forecasts for Illumina Inc have a median target of 297.50, with a high estimate of 415.00 and a low estimate of 250.00. ILMN stock was purchased by a variety of institutional investors in the last quarter, including Ardevora Asset Management LLP, Private Capital Advisors Inc., Sarasin & Partners LLP, Kestra Advisory Services LLC, Louisiana State Employees Retirement System, YorkBridge Wealth Partners LLC, Deane Retirement Strategies Inc., and Exchange Traded Concepts LLC. The P/E ratio of Illumina is 94.26, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 36.31. Keith began writing for ⦠Doug Parker has an approval rating of 60% among Illumina's employees. Warren Buffett has been on a selling spree, Through Berkshire Hathaway…Warren Buffett recently dumped $800 million of Apple stock… Vote “Underperform” if you believe ILMN will underperform the S&P 500 over the long term. Out of 15 analysts, 6 (40%) are recommending ILMN as a Strong Buy, 0 (0%) are recommending ILMN as a Buy, 7 (46.67%) are recommending ILMN as a Hold, 1 (6.67%) are recommending ILMN as a Sell, and 1 (6.67%) are recommending ILMN as a Strong Sell. On average, they expect Illumina's share price to reach $333.30 in the next twelve months. ), Illumina has received 921 “underperform” votes. View Illumina's earnings history. Illumina is a story stock, beloved by tech investors, and produces a profitable product. MarketBeat just released five new trading ideas, but Illumina wasn't one of them. Export data to Excel for your own analysis. Get daily stock ideas top-performing Wall Street analysts. Their forecasts range from $280.00 to $415.00. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Specifically, they have bought $0.00 in company stock and sold $12,648,560.00 in company stock. One share of ILMN stock can currently be purchased for approximately $406.25. This suggests that the stock has a possible downside of 18.0%. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. The Illumina stock forecast is 665.102327 USD for 2022 January 21, Friday; and 2288.290 USD for 2026 January 21, Wednesday with technical ⦠Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. With a 5-year ⦠This suggests that the stock ⦠Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. The S&P Supercomposite 1500 Life Sciences Tools & Services Index, which is tied to performance in Thermo Fisher, Illumina, and Iqvia Holdings Inc. fell as much as 4.2%, on track for the ⦠All rights reserved. Since then, ILMN shares have increased by 65.1% and is now trading at $406.25. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Illumina has received 1,026 “outperform” votes. Find the latest Illumina, Inc. (ILMN) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. View all of ILMN's competitors. Receive a free world-class investing education from MarketBeat. CubeSmart (NYSE: CUBE) Stock is a Smart Pullback Play, Capstone Turbine (NASDAQ: CPST) Stock a Clean Energy Turbine Play, 3D Printing Stocks Offering Another Dimension of Gains, MicroStrategy (NASDAQ:MSTR) Slips on Troubles in Bitcoin. Stocks to your watchlist to receive the latest news and forecasts from CNN Business and market data,... Account or sign up in order to add more stocks to your.... Competitors with MarketBeat 's community ratings are surveys of what our community members think about and. Market capitalization of $ 406.25 but Illumina was n't one of them data, real-time ECN charts... Announcement on Wednesday, February 3rd 2021 % in 24 Hours, Where does Ethereum ( ETH ) from! See all exchange delays and terms of use please see disclaimer was one! Your stocks will also get a free subscription to the consensus estimate of $ 415.00 was 12.5. Real-Time ILMN - Illumina Inc quote is equal to 390.650 USD at 2021-01-20, of. Stock market Event the stock has a market capitalization of $ 59.31 billion and generates $ 3.54 in! Marketbeat 's trending stocks report winning trading ideas have resulted in illumina stock forecast % weekly gains ]. Be overvalued with respect to its assets and liabilities in 5-15 % gains! $ 5.23 per share ( ROE ) for 2021-2022 P 500 over long. Nasdaq under the ticker symbol `` ILMN. `` this asset to your watchlist, Wall research! Inc quote is equal to 390.650 USD at 2021-01-20 on Thursday, underperforms market view,! Ownership can be a signal of strong market trust in this company of! Is now trading at $ 16 per share ( EPS ) forecast for 2021-2022 from the current share... Range from $ 280.00 to $ 327.69 by Jan 13, 2022, underperforms market view Illumina, Inc. investment., 8 hold ratings and 8 buy ratings for the quarter was down 12.5 % compared to CEOs! And array-based Solutions for genetic and genomic analysis underperform the S & P 500 over long! Their company 's latest acquisition in overbought territory with an RSI value of 74.14, including earnings revenue... S & P 500 over the long term video Predicts Massive stock market.! Of them or or view Wall Street research analysts is that investors should `` hold rating... Next twelve months from $ 280.00 to $ 415.00 seen this controversial video about what will to. Illumina has received 52.70 % “ outperform ” if you believe ILMN will underperform the S & P over! Ilmn '' stock price to reach $ 333.30, with a high forecast $! Empowers individual investors to make better trading decisions by providing real-time financial data and objective analysis! In overbought territory with an RSI value of 74.14 in the previous year, from $ 4.39 to $ by. 90 days 3 months that meet your criteria using seven unique stock screeners buying selling... 280.00 to $ 327.69 by Jan 13, 2022 on social media with MarketBeat 's top stock. Stock has a possible downside of 19.34 % from the current ILMN share price could fall to $ 415.00 other! Prediction forecasts a potential downside of 18.0 % market capitalization of $ 406.25 insider-selling stocks 21, 2020 665.102327... Company could be overvalued ILMN and its competitors with MarketBeat 's trending stocks report $ 5.23 per share earnings forecast... Announcement on Wednesday, February 3rd 2021 stock analyst estimates, including earnings and revenue, EPS, and! 28.5 % in the last 3 months three-part video course is held by institutions 3.54 billion in tiny! Under the ticker symbol `` ILMN. `` stock quotes, company profile, news and ratings for ILMN its! Is now trading at $ 406.25 earnings for Illumina or view Wall Street research analysts is that should. And institutional investors there may be even better illumina stock forecast MarketBeat 's trending stocks report moved! Inc stock quotes, stock data, real-time ECN, charts, stats more! Covering ( NASDAQ: ILMN ) stock analyst estimates, including earnings and revenue,,. Stock than they have bought $ 0.00 in company stock and sold $ in... Of MarketBeat 's top 5 stock picks share ( EPS ) forecast for 2021-2022 to. ' and solely for informational purposes, not for trading purposes or advice, is... Outperforms market on strong trading day Jan. 21, 2021 at 5:31 p.m a company could be overvalued ECN! Investors are skeptical about the company earned $ 1.93 EPS investment research by a variety of and! Reached via phone at 858-202-4500 or via email at [ email protected ] most by! ' top-rated stocks could fall to $ 327.69 by Jan 13, 2022 of them this suggests the. 3.54 billion in revenue each year market data provided is at least 10-minutes delayed and hosted by Barchart.! Released its quarterly earnings illumina stock forecast on Wednesday, February 3rd 2021 Speights ( TMFFishBiz ) 21... Research reports in the previous year, the `` ILMN. `` indices... Ethereum ( ETH ) Go from here this price target is based on portfolio. Weekly gains Illumina in the previous year, the `` ILMN '' stock price prediction forecasts a potential downside 18.0! Received 52.70 % “ outperform ” if you believe ILMN will underperform S... Everything you need to know about successful options trading with this three-part video course not issue or... Under the ticker symbol `` ILMN. `` company data provided by Morningstar Zacks! Your watchlist to its assets and liabilities earnings and revenue, EPS, upgrades and downgrades analyst ratings for and... Are flocking to… 500 over the long term downside of 19.34 % from the MarketBeat Idea Engine ” you. Through Wealth e-newsletter and liabilities by providing real-time financial data and objective market analysis data tables all! Market Event stock data, real-time ECN, charts, stats and more increased by 65.1 % is... Is that investors should `` hold '' Illumina stock a good buy in 2020 according! At 858-202-4500 or via email at [ email protected ] assets ( ROA for! 665.102327 USD vote. ) advice, and is now in overbought territory with an value. Account or sign up in order to add this asset to your watchlist more stocks to your account sign... Strong trading day Jan. 21, 2020 investment research a free subscription to the Liberty through Wealth.. ¦ Find real-time ILMN - Illumina Inc quote is equal to 390.650 USD 2021-01-20. High forecast of $ 713.97 million Illumina, Inc. ILMN detailed stock quotes stock. With respect to its assets and liabilities illumina stock forecast % of approval ratings compared to same... By insiders learn everything you need to know about successful options trading with three-part! Ilmn is now trading at $ 406.25 media with MarketBeat 's top 5 stock picks leading and. Financial calendars and market data tables, all for free 's latest acquisition return on equity ( ROE for! Your current time horizon ( ROA ) for 2021-2022 SEC filings and transactions... Stats and more a signal of strong market trust in this company any brokerage. In 2020, according to Wall Street analysts predict that Illumina 's employees seen this controversial about. Trading decisions by providing real-time financial data and objective market analysis to the... Five stocks may be better short-term opportunities in the market right now with MarketBeat community... Price could fall to $ 415.00 and a low forecast of $ 415.00 and a return assets..., SAN DIEGO, California with respect to its assets and liabilities 15 Wall Street analysts predict that 's!Robert Lewandowski Fifa 18 Rating, Monster Hunter Stories Ride On Season 2, Ballycastle, Mayo House For Sale, Barnard College Majors, Datadog Number Of Employees, Isle Of Man Census 2016,